Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 6/20 | 0.39 |
| ▸ | EGFR | P00533 | 1/20 | 0.39 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21913066 | 0.81 | ADORA1 (0.38) | ADORA1EGFRADORA2BKDM4EALDH1A1 | |
| SCHEMBL21101643 | 0.78 | ADORA1 (0.38) | ADORA1EGFRADORA2BKDM4EALDH1A1 | |
| SCHEMBL21913065 | 0.74 | SMN1; SMN2 (0.39) | KDM4EALDH1A1ATMSMN1; SMN2 | |
| SCHEMBL20041603 | 0.72 | NPC1 (0.43) | KDM4EALDH1A1 | |
| SCHEMBL21913210 | 0.71 | SMN1; SMN2 (0.39) | KDM4EALDH1A1L3MBTL1ATMSMN1; SMN2 | |
| SCHEMBL21101690 | 0.71 | POLB (0.36) | KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL20860629 | 0.68 | — | — | |
| SCHEMBL12799837 | 0.66 | ATM (0.53) | ADORA1EGFRADORA2BKDM4EALDH1A1 | |
| SCHEMBL23969714 | 0.65 | — | — | |
| SCHEMBL22298378 | 0.65 | GPR3 (0.45) | KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3640252-A1 | 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS | UDC Ireland Limited (IE) | 2020-04-22 | — | — | EP | disclosed |